Literature DB >> 8350411

Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.

M J Vincent1, N U Raja, M A Jabbar.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Vpu protein is a transmembrane phosphoprotein which induces rapid degradation of CD4 in the endoplasmic reticulum (ER). To identify sequences in CD4 for Vpu-induced degradation, we generated four chimeric envelope glycoproteins having the ectodomain of HIV-1 gp160, the anchor domain of CD4, and 38, 25, 24, and 18 amino acids (aa) of the CD4 cytoplasmic domain. Using the vaccinia virus-T7 RNA polymerase expression system, we analyzed the expression of chimeric proteins in the presence and absence of Vpu. In singly transfected cells, the chimeric envelope glycoproteins having 38, 24, and 18 aa of the CD4 cytoplasmic domain were endoproteolytically cleaved and biologically active in the fusion of HeLa CD4+ cells. However, one of the chimeras having 25 aa of the CD4 cytoplasmic tail was retained in the ER using the transmembrane ER retention signal and was defective in membrane fusion. Furthermore, biochemical analyses of the coexpressing cells revealed that the Vpu protein induced degradation of the envelope glycoproteins having 38, 25, and 24 aa of the CD4 cytoplasmic tail and degradation occurred in the ER. Consequently, the fusion-competent glycoproteins did not induce the formation of syncytia in HeLa CD4+ cells expressing Vpu. However, the HIV-1 gp160 and chimeric envelope glycoprotein having the membrane-proximal 18 aa of the CD4 cytoplasmic tail were stable and fusion competent in cells expressing Vpu. In addition, we examined the stability of CD4 molecules in the presence of Vpu. Coexpression analyses revealed that the Vpu protein induced degradation of CD4 whereas mutant CD4 having the membrane-proximal 18 aa of the cytoplasmic domain was relatively stable in the presence of Vpu. Taken together, these studies have elucidated that the Vpu protein requires sequences or sequence determinants in the cytoplasmic domain of CD4 to induce degradation of the glycoproteins in the cell.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350411      PMCID: PMC237957     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

Review 1.  Unpacking the incoming influenza virus.

Authors:  A Helenius
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

2.  Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus.

Authors:  Y Koga; M Sasaki; H Yoshida; M Oh-Tsu; G Kimura; K Nomoto
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.

Authors:  R L Willey; F Maldarelli; M A Martin; K Strebel
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment.

Authors:  F Ciampor; P M Bayley; M V Nermut; E M Hirst; R J Sugrue; A J Hay
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

5.  Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.

Authors:  C K Leonard; M W Spellman; L Riddle; R J Harris; J N Thomas; T J Gregory
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

Review 6.  HIV-1 replication and potential targets for intervention.

Authors:  M Stevenson; M Bukrinsky; S Haggerty
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

7.  Influenza virus M2 protein has ion channel activity.

Authors:  L H Pinto; L J Holsinger; R A Lamb
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

8.  Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.

Authors:  S Bour; F Boulerice; M A Wainberg
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 9.  Molecular biology of the human immunodeficiency virus type 1.

Authors:  W A Haseltine
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

Review 10.  Brefeldin A: insights into the control of membrane traffic and organelle structure.

Authors:  R D Klausner; J G Donaldson; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  39 in total

1.  Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus.

Authors:  Angela J Sanchez; Martin J Vincent; Stuart T Nichol
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1.

Authors:  Martin J Vincent; Angela J Sanchez; Bobbie R Erickson; Ajoy Basak; Michel Chretien; Nabil G Seidah; Stuart T Nichol
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 3.  HIV-1 Vpu - an ion channel in search of a job.

Authors:  Klaus Strebel
Journal:  Biochim Biophys Acta       Date:  2013-07-03

Review 4.  The Vpu protein: new concepts in virus release and CD4 down-modulation.

Authors:  Autumn Ruiz; John C Guatelli; Edward B Stephens
Journal:  Curr HIV Res       Date:  2010-04       Impact factor: 1.581

5.  Helix-destabilizing, beta-branched, and polar residues in the baboon reovirus p15 transmembrane domain influence the modularity of FAST proteins.

Authors:  Eileen K Clancy; Roy Duncan
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

6.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Endothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT.

Authors:  Jaehyuk Choi; Jason Walker; Kristina Talbert-Slagle; Paulette Wright; Jordan S Pober; Louis Alexander
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 8.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

9.  Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing.

Authors:  C R Casella; E L Rapaport; T H Finkel
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics.

Authors:  T Luo; S J Anderson; J V Garcia
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.